De Filippis S - Search Results

1

Major Depression in Comorbidity with Substance use Disorders: Patients' Features and Clinical-Neurobiological Rationale of Antidepressant Treatments.

De Filippis S, Martinotti G, Nicoletti F, Mastrostefano A, Trovini G, Pugliese A, Di Nicola M. De Filippis S, et al. Curr Neuropharmacol. 2024 Aug 30. doi: 10.2174/1570159X22666240827165327. Online ahead of print. Curr Neuropharmacol. 2024. PMID: 39219428

2

Switching antipsychotic medication to aripiprazole: position paper by a panel of Italian psychiatrists.

Fagiolini A, Brugnoli R, Di Sciascio G, De Filippis S, Maina G. Fagiolini A, et al. Among authors: de filippis s. Expert Opin Pharmacother. 2015 Apr;16(5):727-37. doi: 10.1517/14656566.2015.1013029. Epub 2015 Feb 12. Expert Opin Pharmacother. 2015. PMID: 25672664 Free article.

3

An improved simple LC-MS/MS method for the measurement of serum aripiprazole and its major metabolite.

Caloro M, Lionetto L, Cuomo I, Simonetti A, Pucci D, De Persis S, Casolla B, Kotzalidis GD, Sciarretta A, De Filippis S, Simmaco M, Girardi P. Caloro M, et al. Among authors: de persis s, de filippis s. J Pharm Biomed Anal. 2012 Mar 25;62:135-9. doi: 10.1016/j.jpba.2012.01.003. Epub 2012 Jan 14. J Pharm Biomed Anal. 2012. PMID: 22300908

4

Nalmefene in Alcohol Use Disorder Subjects with Psychiatric Comorbidity: A Naturalistic Study.

Di Nicola M, De Filippis S, Martinotti G, De Risio L, Pettorruso M, De Persis S, Maremmani AGI, Maremmani I, di Giannantonio M, Janiri L. Di Nicola M, et al. Among authors: de risio l, de persis s, de filippis s. Adv Ther. 2017 Jul;34(7):1636-1649. doi: 10.1007/s12325-017-0546-3. Epub 2017 May 24. Adv Ther. 2017. PMID: 28540656

5

Predictive factors of overall functioning improvement in patients with chronic schizophrenia and schizoaffective disorder treated with paliperidone palmitate and aripiprazole monohydrate.

Girardi P, Del Casale A, Rapinesi C, Kotzalidis GD, Splendori F, Verzura C, Trovini G, Sorice S, Carrus D, Mancinelli I, Comparelli A, De Filippis S, Francomano A, Ballerini A, Marcellusi A, Mennini FS, Ducci G, Sani G, Pompili M, Brugnoli R. Girardi P, et al. Among authors: de filippis s. Hum Psychopharmacol. 2018 May;33(3):e2658. doi: 10.1002/hup.2658. Epub 2018 May 15. Hum Psychopharmacol. 2018. PMID: 29766576

6

Patterns of Management of Patients With Dual Disorder (Psychosis) in Italy: A Survey of Psychiatrists and Other Physicians Focusing on Clinical Practice.

Clerici M, de Bartolomeis A, De Filippis S, Ducci G, Maremmani I, Martinotti G, Schifano F. Clerici M, et al. Among authors: de filippis s, de bartolomeis a. Front Psychiatry. 2018 Nov 13;9:575. doi: 10.3389/fpsyt.2018.00575. eCollection 2018. Front Psychiatry. 2018. PMID: 30483161 Free PMC article.

7

Vortioxetine vs. Other Antidepressants in Patients with Major Depressive Episode With or Without Substance Use Disorder.

Kotzalidis GD, Lombardozzi G, Matrone M, Amici E, Perrini F, Cuomo I, De Filippis S. Kotzalidis GD, et al. Among authors: de filippis s. Curr Neuropharmacol. 2021;19(12):2296-2307. doi: 10.2174/1570159X19666210113150123. Curr Neuropharmacol. 2021. PMID: 33441069 Free PMC article. Clinical Trial.

8

Treatment-resistant schizophrenia: Addressing white matter integrity, intracortical glutamate levels, clinical and cognitive profiles between early- and adult-onset patients.

Matrone M, Kotzalidis GD, Romano A, Bozzao A, Cuomo I, Valente F, Gabaglio C, Lombardozzi G, Trovini G, Amici E, Perrini F, De Persis S, Iasevoli F, De Filippis S, de Bartolomeis A. Matrone M, et al. Among authors: de persis s, de filippis s, de bartolomeis a. Prog Neuropsychopharmacol Biol Psychiatry. 2022 Mar 2;114:110493. doi: 10.1016/j.pnpbp.2021.110493. Epub 2021 Dec 7. Prog Neuropsychopharmacol Biol Psychiatry. 2022. PMID: 34883221

9

Differential Response to Three Antidepressants in Patients with Major Depressive Episode Who Suffered Covid-19-Related Trauma.

De Filippis S, Lombardozzi G, Matrone M, Amici E, Trovini G, Perrini F, Di Giovanni A, Giovanetti V, Kotzalidis GD. De Filippis S, et al. Curr Neuropharmacol. 2022 Nov 15;20(12):2393-2407. doi: 10.2174/1570159X20666220310122849. Curr Neuropharmacol. 2022. PMID: 35272591 Free PMC article.

10

Effectiveness of Vortioxetine in Patients with Major Depressive Disorder in Real-World Clinical Practice in Italy: Results from the RELIEVE Study.

De Filippis S, Pugliese A, Christensen MC, Rosso G, Di Nicola M, Simonsen K, Ren H. De Filippis S, et al. Neuropsychiatr Dis Treat. 2022 Aug 9;18:1665-1677. doi: 10.2147/NDT.S375294. eCollection 2022. Neuropsychiatr Dis Treat. 2022. PMID: 35971416 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

122 results

Search Page

Filters